Search details
1.
Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank.
Am J Hum Genet
; 110(4): 648-662, 2023 04 06.
Article
in English
| MEDLINE | ID: mdl-36977412
2.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36827971
3.
Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.
J Med Genet
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38834293
4.
Case-inspired exploration of renin mutations in autosomal dominant tubulointerstitial kidney disease: not all paths lead to the endoplasmic reticulum.
Pediatr Nephrol
; 2024 Mar 23.
Article
in English
| MEDLINE | ID: mdl-38520530
5.
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast Cancer Res
; 25(1): 72, 2023 06 20.
Article
in English
| MEDLINE | ID: mdl-37340476
6.
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Br J Cancer
; 128(1): 137-147, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36323878
7.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37076566
8.
Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan.
Breast Cancer Res Treat
; 202(2): 377-387, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37528266
9.
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.
Eur J Epidemiol
; 38(10): 1053-1068, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37789226
10.
Genetic testing for hereditary breast cancer in Poland: 1998-2022.
Hered Cancer Clin Pract
; 21(1): 9, 2023 Jun 13.
Article
in English
| MEDLINE | ID: mdl-37312208
11.
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.
Breast Cancer Res
; 24(1): 69, 2022 10 21.
Article
in English
| MEDLINE | ID: mdl-36271417
12.
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Br J Cancer
; 127(1): 84-91, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35256754
13.
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.
J Med Genet
; 58(5): 305-313, 2021 05.
Article
in English
| MEDLINE | ID: mdl-32546565
14.
Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland.
Hered Cancer Clin Pract
; 20(1): 12, 2022 Apr 05.
Article
in English
| MEDLINE | ID: mdl-35382848
15.
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Hered Cancer Clin Pract
; 20(1): 11, 2022 Mar 21.
Article
in English
| MEDLINE | ID: mdl-35313928
16.
Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife.
Kidney Int
; 99(6): 1451-1458, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33309955
17.
PALB2 mutations and prostate cancer risk and survival.
Br J Cancer
; 125(4): 569-575, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34006922
18.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Genet Med
; 23(9): 1726-1737, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34113011
19.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Am J Obstet Gynecol
; 225(1): 51.e1-51.e17, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33493488
20.
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res
; 22(1): 25, 2020 Feb 26.
Article
in English
| MEDLINE | ID: mdl-32102695